Madrigal Pharmaceuticals

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).

Feb 06, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Waltham, MA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Waltham, MA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Miami, FL, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals New York, NY, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals TX, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Seattle, WA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Philadelphia, PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Chicago, IL, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Jackson, MS, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Oakland, CA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Waltham, MA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Boston, MA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals NH, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).
Feb 06, 2026
Full time
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH).